NCT07025538 2026-02-23
Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation
City of Hope Medical Center
Phase 1 Suspended
Clinical Trials
8 trialsNCT06827054 2026-02-18
Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids
Roswell Park Cancer Institute
Phase 2 Not yet recruiting
NCT06895473 2026-01-30
Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome
OHSU Knight Cancer Institute
Phase 2 Recruiting
NCT06569316 2026-01-29
Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
Mayo Clinic
Phase NA Recruiting
NCT07349771 2026-01-20
Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial
Mayo Clinic
Phase 2 Not yet recruiting
NCT03996265 2026-01-15
Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors
University of Rochester
Phase 3 Active not recruiting
NCT07184294 2025-09-19
Different Types of Massage Therapy to Reduce Anxiety During Chemotherapy Infusion in Patients With Cancer
City of Hope Medical Center
Phase NA Recruiting
NCT06500377 2025-07-11
Comparing the Impact of Four Types of Meditation Practices for Relaxation in Cancer Survivors
City of Hope Medical Center
Phase NA Recruiting